S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
P-453 *Program Revision (see p. 267A): Gender specific characteristics of 15,288 hypertensive patients at high coronary risk. The value trial
Sverre E. Kjeldsen,Stevo Julius,Hans R. Brunner,Lennart Hansson,Marc Henis,Steffan Ekman,John H. Laragh,Gordon T. McInnes,Beverly Smith,Marc Weber,Alberto Zanchetti +10 more
Journal ArticleDOI
Influence of age and gender on preventing myocardial infarction by antihypertensive treatment and aspirin in the hot study.
Journal ArticleDOI
Cardiac remodeling and diastolic dysfunction precede non mi-related heart failure in high-risk hypertensive patients: the life echo substudy.
Marcello Chinali,Gerard P. Aurigemma,Peter M. Okin,Eva Gerdts,Kristian Wachtell,Sverre E. Kjeldsen,Stevo Julius,Bjö,rn Dahlö,Giovanni de Simone,Richard B. Devereux +10 more
TL;DR: The last echocardiographic exam performed before the HF event showed a significant reduction in relative wall thickness and a mild increase in LV diameter and a significant increase in mitral E/A ratio paired with shortening of the IVRT.
Journal ArticleDOI
Increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.
TL;DR: Both arterial and venous plasma adrenaline and noradrenaline concentrations were elevated in 20 middle-aged men with long-standing, untreated essential hypertension compared to 19 normotensive control men, consistent with raised adrenal adrenaline release and release of norADrenaline from the peripheral vascular beds of the forearm.
Journal ArticleDOI
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972–3
TL;DR: Drug treatment of mild hypertensive men initiated in the 1970s did not reduce mortality at first myocardial infarction or total mortality, however, during the period when large changes in hypertension treatment practices occurred into regimes with more use of combination therapies including metabolically neutral drugs at lower doses, beneficial effects on MI mortality could be observed.